Product Wiki · Recalls · Health Canada — Medical Devices

Idylla™ EGFR mutation test — recall 75667

Health Canada — Medical Devices · Canada · 2024-06-14 · Type II

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Agency
Health Canada — Medical Devices
Recall identifier
75667
Date of alert
2024-06-14
Country / jurisdiction
Canada
Risk level
Type II
Risk type
recall
Product category
Haematology
Product type
Medical devices
Reported risk: Biocartis has identified the potential for false positive results to be generated for the S768I target when using the Idylla™ EGFR mutation test, when tests are conducted with low sample input. Recall start date: May 27, 2024
Primary source: https://recalls-rappels.canada.ca/en/alert-recall/idyllatm-egfr-mutation-test

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.